Bluefin Capital Management, LLC Bausch Health Companies Inc. Transaction History
Bluefin Capital Management, LLC
- $1.3 Billion
- Q3 2024
A detailed history of Bluefin Capital Management, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Bluefin Capital Management, LLC holds 30,000 shares of BHC stock, worth $220,200. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$220,200% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BHC
# of Institutions
253Shares Held
254MCall Options Held
5.53MPut Options Held
16.5M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$255 Million2.88% of portfolio
-
Goldentree Asset Management LP New York, NY29.4MShares$216 Million21.8% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$194 Million14.7% of portfolio
-
National Bank Of Canada15.6MShares$115 Million0.18% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$95.4 Million0.26% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.66B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...